Zura Bio Income Statement (2021-2026) | ZURA

Income Statement Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter) 7.50M0.09M0.41M15.69M4.88M28.23M3.96M6.92M3.59M5.54M6.03M9.24M10.47M8.70M11.95M10.96M14.75M
Selling, General & Administrative (Quarter) 0.32M0.84M0.65M1.66M2.83M5.67M6.22M3.91M4.79M6.22M13.29M6.49M8.78M9.36M7.57M7.46M10.75M
Operating Expenses (Quarter) 7.82M0.93M1.07M17.35M7.72M33.91M10.19M10.83M8.38M11.76M19.32M15.73M19.25M18.06M19.52M18.41M25.50M
Operating Income (Quarter) -7.82M-0.93M-1.07M-17.35M-7.72M-33.91M-10.19M-10.83M-8.38M-11.76M-19.32M-15.73M-19.25M-18.06M-19.52M-18.41M-25.50M
EBIT (Quarter) -7.82M-0.93M-1.07M-17.35M-7.72M-33.91M-10.19M-10.83M-8.38M-11.76M-19.32M-15.73M-19.25M-18.06M-19.52M-18.41M-25.50M
Non-operating items
Non Operating Investment Income (Quarter) 0.02M0.18M0.69M1.19M
Interest & Investment Income (Quarter) 14.0042.00224.000.01M0.00M0.81M1.37M1.22M2.20M2.46M2.13M1.82M1.72M1.53M1.28M1.32M
Other Non Operating Income (Quarter) 0.00M-0.03M0.01M-0.01M0.41M0.99M-1.38M0.02M0.00M0.02M-0.02M-0.01M0.35M-0.05M-0.04M-0.04M
Non Operating Income (Quarter) 0.56M3.34M1.00M1.32M-2.08M-0.12M1.92M2.35M0.63M1.43M-1.38M2.11M1.81M2.07M1.48M1.24M1.28M
Net income details
EBT (Quarter) -7.82M-0.93M-1.10M-2.23M-9.79M-34.02M-8.27M-8.47M-7.75M-10.33M-20.70M28.21M-17.44M-15.99M-18.04M-18.14M-24.22M
Profit After Tax (Quarter) 7.80M-0.93M-1.10M-15.89M-9.59M-34.02M-8.27M-8.68M-7.75M-10.33M-20.70M-13.62M-17.44M-15.99M-18.04M-17.15M-24.22M
Income from Non-Controlling Interests (Quarter) -0.20M
Income from Continuing Operations (Quarter) -7.82M-0.93M-1.10M-2.23M-9.79M-34.02M-8.27M-8.47M-7.75M-10.33M-20.70M28.21M-17.44M-15.99M-18.04M-18.14M-24.22M
Consolidated Net Income (Quarter) -7.82M-0.93M-1.10M-2.23M-9.79M-34.02M-8.27M-8.47M-7.75M-10.33M-20.70M28.21M-17.44M-15.99M-18.04M-18.14M-24.22M
Income towards Parent Company (Quarter) -7.82M-0.93M-1.10M-2.23M-9.79M-34.02M-8.27M-8.47M-7.75M-10.33M-20.70M28.21M-17.44M-15.99M-18.04M-18.14M-24.22M
Preferred Dividend Payments (Quarter) 0.20M7.02M2.34M2.24M2.83M2.04M
Net Income towards Common Stockholders (Quarter) -7.82M-0.93M-1.10M-22.54M-9.79M-44.90M-8.27M-6.28M-0.73M-12.67M-22.94M-9.05M-17.44M-15.99M-20.04M-45.88M-24.22M
Additional items
EPS (Basic) (Quarter) -0.07M-9.54-2.87-98.81-2.76-1.31-0.18-0.19-0.02-0.17-0.26-0.12-0.19-0.17-0.21-0.49-0.22
EPS (Diluted) (Quarter) -0.07M-9.54-2.87-98.81-2.76-1.31-0.18-0.19-0.02-0.17-0.26-0.12-0.19-0.17-0.21-0.49-0.22
Shares Outstanding (Quarter) 0.45M108.000.10M0.38M0.23M3.55M34.30M46.88M33.06M46.91M74.95M87.34M75.07M92.96M94.29M94.56M94.16M112.22M
Shares Outstanding (Diluted) (Quarter) 108.000.10M0.38M0.23M3.55M34.30M46.88M33.06M46.91M74.95M87.34M75.07M92.96M94.29M94.56M94.16M112.22M
EBITDA (Quarter) -7.82M-0.93M-1.07M-17.35M-7.72M-33.91M-10.19M-10.83M-8.38M-11.76M-19.32M-15.73M-19.25M-18.06M-19.52M-18.41M-25.50M
Interest Expenses (Quarter) 0.03M6.42M0.01M0.00M0.09M0.10M0.04M0.06M0.10M0.10M0.10M0.10M0.10M0.20M